QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
NASDAQ:MEIP

MEI Pharma ESG Rating & Sustainability Data

$0.24
0.00 (0.00%)
(As of 03/20/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.23
$0.25
50-Day Range
$0.21
$0.35
52-Week Range
$0.20
$1.87
Volume
1.35 million shs
Average Volume
1.14 million shs
Market Capitalization
$32.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.43

Key ESG Takeaways for MEI Pharma

The keytakeaways are AI-generated and highlight the main contributors behind the net impact scores of MEI Pharma. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • MEI Pharma seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is driven by its Clinical research services for cancer product.
  • MEI Pharma uses resources or causes negative impacts mostly in categories , , and . The negative contribution in the impact category is driven by its Clinical research services for cancer product.

MEIP Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+74.0%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+77.1%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+68.9%
Society First
Value set that emphasizes society impacts over other impacts.
+39.0%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+87.8%
Health First
Value set that emphasizes health impacts over other impacts.
+86.0%

MEI Pharma ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+1.18
+1.18
+1.71
+1.71
+0.01
+0.01
-0.01
-0.01
+0.00
-0.00
+0.03
+0.04
+0.00
+0.00
+3.38
+3.38
-0.00
+0.00
+0.00
-1.94
-1.94
-0.54
+5.33
+5.87
-0.00
+0.40
+0.41
0.00
+0.00
-0.00
+0.01
+0.01
-0.00
+0.26
+0.26
-0.45
-0.45
+0.00
-0.05
-0.05
+0.00
-0.02
-0.02
+0.00
-0.01
-0.01
+0.00
-0.33
-0.32
+0.00

Upright Model Version 0.7.100
ESG Data Last Updated: January 31, 2023

About Upright's Net Impact Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.













MEI Pharma ESG Rating - Frequently Asked Questions

How is MEI Pharma doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, MEI Pharma has a net impact ratio of 74.0%, indicating an overall positive sustainability impact. MEI Pharma seems to create the most significant positive value in the categories of Physical diseases, Creating knowledge, and Taxes. MEI Pharma uses resources or causes negative impacts mostly in the categories of Scarce human capital, Physical diseases, and GHG emissions. Learn more on the sustainability of MEI Pharma.

This page (NASDAQ:MEIP) was last updated on 3/20/2023 by MarketBeat.com Staff